[1] COLLINS FL, WILLIAMS JO, BLOOM AC, et al. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss. Bone. 2017;97:94-104.
[2] SOYSA NS, ALLES N. Osteoclast function and bone-resorbing activity: An overview. Biochem Biophys Res Commun. 2016;476(3):115-120.
[3] BOYLE WJ, SIMONET WS, LACEY DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-342.
[4] WADA T, NAKASHIMA T, HIROSHI N, et al. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12(1):17-25.
[5] LEE K, CHUNG YH, AHN H, et al. Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation. Int J Biol Sci. 2016;12(2):235-245.
[6] GLICK D, BARTH S, MACLEOD KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3-12.
[7] DESELM CJ, MILLER BC, ZOU W, et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell. 2011;21(5):966-974.
[8] MORTENSEN M, SOILLEUX EJ, DJORDJEVIC G, et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med. 2011;208(3):455-467.
[9] WANG K, NIU J, KIM H, et al. Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy. J Mol Cell Biol. 2011;3(6):360-368.
[10] MIZUSHIMA N, KOMATSU M. Autophagy: Renovation of Cells and Tissues. Cell. 2011;147(4):728-741.
[11] KABEYA Y, MIZUSHIMA N, YAMAMOTO A, et al. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci. 2004;117(13):2805-2812.
[12] LOOS B, ENGELBRECHT AM, LOCKSHIN RA, et al. The variability of autophagy and cell death susceptibility: Unanswered questions. Autophagy. 2013;9(9):1270-1285.
[13] SCRIVO A, BOURDENX M, PAMPLIEGA O, et al. Selective autophagy as a potential therapeutic target for neurodegenerative disorders. Lancet Neurol. 2018;17(9):802-815.
[14] LIPPAI M, LŐW P. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. Biomed Res Int. 2014;2014:832704.
[15] KIM CJ, SHIN SH, KIM BJ, et al. The Effects of Kaempferol-Inhibited Autophagy on Osteoclast Formation. Int J Mol Sci. 2018;19(1):125.
[16] LI RF, CHEN G, REN JG, et al. The adaptor protein p62 is involved in RANKL-induced autophagy and osteoclastogenesis. J Histochem Cytochem. 2014;62(12):879-888.
[17] LIN NY, STEFANICA A, DISTLER JHW. Autophagy A key pathway of TNF-induced inflammatory bone loss. Autophagy. 2013;9(8):1253-1255.
[18] HELFRICH MH, HOCKING LJ. Genetics and aetiology of Pagetic disorders of bone. Arch Biochem Biophys. 2008;473(2):172-182.
[19] FLORES K, YADAV SS, KATZ AA, et al. The nuclear translocation of mitogen-activated protein kinases: molecular mechanisms and use as novel therapeutic target. Neuroendocrinology. 2019;108(2):121-131.
[20] LEE K, SEO I, CHOI MH, et al. Roles of mitogen-activated protein kinases in osteoclast biology. Int J Mol Sci. 2018;19(10):3004.
[21] GIRIO A, MONTERO JC, PANDIELLA A, et al. Erk5 is activated and acts as a survival factor in mitosis. Cell Signal. 2007;19(9): 1964-1972.
[22] LEE K, CHUNG YH, AHN H, et al. Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation. Int J Biol Sci. 2016;12(2):235-245.
[23] BOEHM C, HAYER S, KILIAN A, et al. The alpha-Isoform of p38 MAPK Specifically Regulates Arthritic Bone Loss. J Immunol. 2009;183(9): 5938-5947.
[24] KOLCH W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol. 2005;6(11):827-837.
[25] KIM JH, HONG SK, WU PK, et al. Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels. Exp Cell Res. 2014;327(2):340-352.
[26] HUANG H, NI H, MA K, et al. ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy. Am J Transl Res. 2019;11(9):5472-5486.
[27] LI X, FENG K, LI J, et al. Curcumin Inhibits Apoptosis of Chondrocytes through Activation ERK1/2 Signaling Pathways Induced Autophagy. Nutrients. 2017;9(4):414
[28] OH JH, LEE JY, PARK JH, et al. Obatoclax regulates the proliferation and fusion of osteoclast precursors through the inhibition of ERK activation by RANKL. Mol Cells. 2015;38(3):279-284.
[29] HE Y, STASER K, RHODES SD, et al. Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity. Plos One. 2011;6(9):e24780.
[30] YIN Z, ZHU W, WU Q, et al. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways. Eur J Pharmacol. 2019; 859:172550.
[31] JIN H, SHAO Z, WANG Q, et al. Sclareol prevents ovariectomy-induced bone loss in vivo and inhibits osteoclastogenesis in vitro via suppressing NF-κB and MAPK/ERK signaling pathways. Food Funct. 2019;10(10): 6556-6567.
[32] CAO B, DAI X, WANG W. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca(2+) -calcineurin-NFATc1 pathway. J Cell Physiol. 2019;234(5):6831-6841.
[33] CHUNG YH, CHOI B, SONG DH, et al. Interleukin-1β promotes the LC3-mediated secretory function of osteoclast precursors by stimulating the Ca²⁺-dependent activation of ERK. Int J Biochem Cell Biol. 2014;54:198-207.
[34] LOVERIDGE CJ, VAN’T HOF RJ, CHARLESWORTH G, et al. Analysis of Nkx3.1: Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Sci Rep. 2017;7:13241.
[35] ADAM C, GLUECK L, EBERT R, et al. The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization. Bone. 2018;111:49-58.
[36] MA C, GENG B, ZHANG X, et al. Fluid Shear Stress Suppresses Osteoclast Differentiation in RAW264.7 Cells through Extracellular Signal-Regulated Kinase 5 (ERK5) Signaling Pathway. Med Sci Monit. 2020;26:e918370.
[37] AMANO S, CHANG YT, FUKUI Y. ERK5 Activation Is Essential for Osteoclast Differentiation. Plos One. 2015;10(4):e0125054.
[38] KUMAR A, SINGH UK, KINI SG, et al. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases. Future Med Chem. 2015;7(15):2065-2086.
[39] OTERO JE, DAI S, FOGLIA D, et al. Defective Osteoclastogenesis by IKK beta-null Precursors Is a Result of Receptor Activator of NF-kappa B Ligand (RANKL)-induced JNK-dependent Apoptosis and Impaired Differentiation. J Biol Chem. 2008;283(36):24546-24553.
[40] WU H, HU B, ZHOU X, et al. Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway. Cell Death Dis. 2018;9(5):498.
[41] KE D, FU X, XUE Y, et al. IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro. Biochem Biophys Res Commun. 2018; 497(3):890-896.
[42] CHUNG YH, JANG Y, CHOI B, et al. Beclin-1 Is Required for RANKL-Induced Osteoclast Differentiation. J Cell Physiol. 2014;229(12):1963-1971.
[43] KE D, JI L, WANG Y, et al. JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway. Faseb J. 2019;33(10):11082-11095.
[44] CONG Q, JIA H, LI P, et al. p38 alpha MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging- dependent manner. Sci Rep. 2017;7:45964.
[45] CHEN J, LONG F. mTOR signaling in skeletal development and disease. Bone Res. 2018;6:1.
[46] HE Y, SHE H, ZHANG T, et al. p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1. J Cell Biol. 2018;217(1):315-328.
[47] HUANG RH, QUAN YJ, CHEN JH, et al. Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway. Cell Physiol Biochem. 2017;41(5):1851-1864.
[48] ZHOU J, FAN Y, ZHONG J, et al. TAK1 mediates excessive autophagy via p38 and ERK in cisplatin-induced acute kidney injury. J Cell Mol Med. 2018;22(5):2908-2921.
[49] KAWANO A, ARIYOSHI W, YOSHIOKA Y, et al. Docosahexaenoic acid enhances M2 macrophage polarization via the p38 signaling pathway and autophagy. J Cell Biochem. 2019;120(8):12604-12617.
[50] BOYLE DL, HAMMAKER D, EDGAR M, et al. Differential Roles of MAPK Kinases MKK3 and MKK6 in Osteoclastogenesis and Bone Loss. Plos One. 2014;9(1):e84818.
[51] CHUNG YH, JANG Y, CHOI B, et al. Beclin-1 is required for RANKL-induced osteoclast differentiation. J Cell Physiol. 2014;229(12):1963-1971.
[52] ZHAO H, LIU X, ZOU H, et al. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways. Cytokine. 2015;71(2):199-206.
[53] WHITEHOUSE CA, WATERS S, MARCHBANK K, et al. Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity. Proc Natl Acad Sci U S A. 2010; 107(29):12913-12918.
|